HCM
GILD icon

Herndon Capital Management’s Gilead Sciences GILD Stock Holding History

Herndon Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$20.8M Sell
293,842
-20,073
-6% -$1.34M 3.16% 4
2017
Q1 		$21.3M Buy
313,915
+74,417
+31% +$5.23M 3.11% 3
2016
Q4 		$17.1M Sell
239,498
-180,677
-43% -$13.4M 2.27% 23
2016
Q3 		$33.2M Sell
420,175
-150,465
-26% -$12.2M 1.66% 34
2016
Q2 		$47.6M Sell
570,640
-308,664
-35% -$27.4M 1.83% 31
2016
Q1 		$80.8M Sell
879,304
-136,282
-13% -$12.3M 2.02% 29
2015
Q4 		$103M Sell
1,015,586
-88,435
-8% -$9.2M 2.17% 28
2015
Q3 		$108M Sell
1,104,021
-93,176
-8% -$10.3M 2.11% 25
2015
Q2 		$140M Sell
1,197,197
-128,001
-10% -$14M 2.33% 24
2015
Q1 		$130M Sell
1,325,198
-152,750
-10% -$15.5M 1.94% 33
2014
Q4 		$139M Sell
1,477,948
-331,338
-18% -$34.3M 1.9% 32
2014
Q3 		$194M Buy
1,809,286
+795,250
+78% +$77.9M 2.56% 9
2014
Q2 		$84.1M Buy
+1,014,036
New +$78.9M 1.05% 45
2013
Q3 		– Sell
-105,459
Closed -$5.41M – 186
2013
Q2 		$5.41M Buy
+105,459
New +$5.5M 0.08% 63

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Herndon Capital Management's GILD Position: Q2 2017 in Review

Herndon Capital Management reduced its Gilead Sciences (GILD) stake by 6.4% in Q2 2017, selling an estimated $1.34M and leaving 293,842 shares worth $20.8M. The position accounts for 3.16% of the portfolio, ranked #4.

Herndon Capital Management first reported a position in GILD in Q2 2013 and has held it in 14 quarters since. The position peaked at $194M in Q3 2014. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Herndon Capital Management held 293,842 shares of Gilead Sciences worth $20.8M as of Q2 2017.
  • Herndon Capital Management sold 20,073 Gilead Sciences shares in Q2 2017, an estimated $1.34M.
  • Gilead Sciences made up 3.16% of Herndon Capital Management's portfolio in Q2 2017, its #4 holding.
  • Herndon Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 14 quarters since.
  • Herndon Capital Management's Gilead Sciences position peaked at $194M in Q3 2014.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Herndon Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.